Susquehanna International Group, LLP Amicus Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 222,087 shares of FOLD stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

222,087

Previous 303,448 26.81%

Holding current value

$2.15 Million

Previous $3.01 Million 21.23%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$9.55 - $12.09 $776,997 - $983,654	-81,361 Reduced 26.81%	222,087 $2.37 Million
Q2 2024 Aug 15, 2024	BUY	$9.04 - $11.75 $1.82 Million - $2.37 Million	201,825 Added 198.6%	303,448 $3.01 Million
Q1 2024 May 07, 2024	SELL	$11.43 - $14.24 $701,264 - $873,666	-61,353 Reduced 37.65%	101,623 $1.2 Million
Q4 2023 Feb 14, 2024	SELL	$9.97 - $14.52 $974,986 - $1.42 Million	-97,792 Reduced 37.5%	162,976 $2.31 Million
Q3 2023 Nov 14, 2023	SELL	$11.78 - $13.86 $1.23 Million - $1.44 Million	-104,043 Reduced 28.52%	260,768 $3.17 Million
Q2 2023 Aug 11, 2023	BUY	$10.72 - $13.3 $518,204 - $642,922	48,340 Added 15.27%	364,811 $4.58 Million
Q1 2023 May 16, 2023	BUY	$10.91 - $13.54 $2.17 Million - $2.69 Million	198,883 Added 169.14%	316,471 $3.51 Million
Q4 2022 Feb 14, 2023	SELL	$9.89 - $12.7 $1.93 Million - $2.48 Million	-195,062 Reduced 62.39%	117,588 $1.44 Million
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $2.5 Million - $3.24 Million	254,274 Added 435.58%	312,650 $3.26 Million
Q2 2022 Aug 15, 2022	SELL	$6.23 - $11.12 $732,554 - $1.31 Million	-117,585 Reduced 66.82%	58,376 $627,000
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $365,086 - $577,474	-46,272 Reduced 20.82%	175,961 $1.67 Million
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $905,757 - $1.15 Million	-92,236 Reduced 29.33%	222,233 $2.57 Million
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $823,194 - $1.12 Million	94,187 Added 42.76%	314,469 $3 Million
Q2 2021 Aug 11, 2021	SELL	$8.71 - $10.72 $941,350 - $1.16 Million	-108,077 Reduced 32.91%	220,282 $2.12 Million
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $2.52 Million - $6.54 Million	274,090 Added 505.06%	328,359 $3.24 Million
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $1.48 Million - $2.74 Million	-109,932 Reduced 66.95%	54,269 $1.25 Million
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $863,397 - $1.06 Million	-66,982 Reduced 28.97%	164,201 $2.32 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $231,299 - $409,603	26,106 Added 12.73%	231,183 $3.49 Million
Q1 2020 May 15, 2020	BUY	$6.63 - $11.16 $776,717 - $1.31 Million	117,152 Added 133.24%	205,077 $1.9 Million
Q4 2019 Feb 14, 2020	SELL	$7.48 - $10.75 $1.56 Million - $2.24 Million	-208,087 Reduced 70.3%	87,925 $856,000
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $671,410 - $1.11 Million	-83,717 Reduced 22.05%	296,012 $2.37 Million
Q2 2019 Aug 16, 2019	BUY	$10.96 - $14.4 $1.89 Million - $2.49 Million	172,769 Added 83.48%	379,729 $4.74 Million
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $1.61 Million - $2.12 Million	147,172 Added 246.16%	206,960 $2.58 Million
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $152,222 - $244,137	18,165 Added 43.64%	59,788 $573,000
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $6.69 Million - $9.55 Million	-577,114 Reduced 93.27%	41,623 $503,000
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $6.61 Million - $8.6 Million	-503,287 Reduced 44.86%	618,737 $9.67 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $2.36 Million - $2.94 Million	171,711 Added 18.07%	1,122,024 $16.9 Million
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $2.73 Million - $3.54 Million	217,985 Added 29.77%	950,313 $13.7 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $8.6 Million - $11.6 Million	732,328	732,328 $11 Million

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.72B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Amicus Therapeutics, Inc. Transaction History